Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
Browse and view ASGCT's gene editing-focused content on-demand. This resource is made available exclusively for ASGCT members.
ASGCT membership unlocks incredible discounts and on-demand access to a rich archive documenting the history of cell and gene therapy. Take the next step in your career by becoming an ASGCT member.
Join
March 9, 2022 This program from ASGCT and the Brazilian Association of Cellular and Genetic Therapy (ABTCel-Gen) brings together speakers from the U.S. and Brazil to share their expertise on vaccine technology and gene editing. 🔒
June 14, 2024 The goal of this interactive discussion was to sustain the ongoing discourse regarding the utilization of CRISPR/Cas9 in conjunction with older technologies in order to reimagine gene and cell therapy treatments, particularly for Duchenne Muscular Dystrophy (DMD). 🔒
December 15, 2023 CRISPR technology has opened up new possibilities in precision medicine and has the potential to revolutionize the treatment of many currently incurable diseases. 🔒
April 4, 2024 During this April 2024 briefing to Congressional staff, ASGCT members gaive an overview of gene editing techniques and applications, hold a discussion about the clinical trials process, and talk about why these technologies can be an important tool for the rare disease patient community. 🔒
July 14, 2023 During her talk, Dr. Jing Liao walks attendees through various key gene editing technologies in the field. 🔒
October 22, 2021 Dr. Ben Kleinstiver explains how he became a genome editor, the genome editing technolgoies his lab researches, pre-CRISPR genome editing, how CRISPR and Cas9 work, and more. 🔒
October 18, 2023 Discuss advanced technologies for safer genomic editing. Learn how these insights support human gene therapy studies. 🔒
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico